Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yunnan Benshan Pharmaceutical is a pharmaceutical enterprise based in Kunming, China, specializing in the modernization and production of traditional ethnic medicines, particularly Dai medicine. The company's product portfolio is founded on the classic formulas of the renowned Dai doctor Chen Benshan, targeting therapeutic areas such as gynecology, orthopedics, pediatrics, and geriatrics. Its flagship commercial products include the Xiaojie’an Capsule, widely used for the treatment of uterine fibroids and mammary hyperplasia, and Guantongshu for rheumatic conditions. Yunnan Benshan operates multiple GMP-certified production lines for various dosage forms, including capsules, tablets, and granules. The company maintains a strong focus on integrating ancient herbal wisdom with contemporary scientific research and manufacturing standards to provide effective treatments for common chronic conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yunnan Benshan Pharmaceutical.